Journal: Frontiers in Veterinary Science
Article Title: Antiviral activity of nitazoxanide against pseudorabies virus infection in vitro
doi: 10.3389/fvets.2025.1623545
Figure Lengend Snippet: Antiviral property of NTZ against the PRV HuN-LD strain in vitro . (A–C,G) Vero cells were pre-treated with varying concentrations of NTZ (12.5, 25.0, and 50.0 μM), and then infected with PRV at a MOI of 0.1. At 24 hpi, both the cells and supernatants were collected for RT-qPCR (A) , TCID 50 (B) , western blotting (C) , and IFA (G) assays to evaluate viral replication. (D–F,G) PK15 cells were pre-treated with varying concentrations of NTZ (12.5, 25.0, and 50.0 μM), and then infected with PRV at a MOI of 0.1. Following a 24-hpi period, both the cells and supernatants were harvested for RT-qPCR (D) , TCID 50 (E) , western blotting (F) , and IFA (G) assays to evaluate viral replication. (H) Vero cells were pre-treated with NTZ (50.0 μM) for 1 h, and then infected with PRV at MOIs of 0.5, 0.1 or 0.02. Supernatants and cells were collected at 24 hpi to quantify viral titers.
Article Snippet: NTZ ( ) was purchased from MedChemExpress and dissolved in dimethyl sulfoxide (DMSO) to achieve a final concentration of 250 mM.
Techniques: In Vitro, Infection, Quantitative RT-PCR, Western Blot